HC Wainwright Predicts Reduced Earnings for Tourmaline Bio
Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Investment analysts at HC Wainwright lowered their Q2 2025 earnings estimates for shares of Tourmaline Bio in a research note issued on Monday, May 5th. HC Wainwright analyst Y. Chen now forecasts that the company will earn ($0.91) per share for the quarter, down from their previous […]
Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Investment analysts at HC Wainwright lowered their Q2 2025 earnings estimates for shares of Tourmaline Bio in a research note issued on Monday, May 5th. HC Wainwright analyst Y. Chen now forecasts that the company will earn ($0.91) per share for the quarter, down from their previous […]
